DVP/ FPLC system

The contract pertains to the procurement of a Fast Protein Liquid Chromatography (FPLC) system by the Laboratory of Immunoregulation (OVRR/DVP) within the Food and Drug Administration. This equipment is essential for purifying peptides and proteins as part of a research project focused on understanding the structure and function of the SARS-CoV-2 spike protein. The project aims to investigate how antibodies induced by vaccines or natural infections, as well as fusion inhibitors like peptides, neutralize the SARS-CoV-2 virus. The contract reference number is PO# 75F40124P00179, and it was forecasted on March 11, 2026. While the solicitation number and place of performance details are not specified, the initiative falls under the NAICS code 334516, which relates to electronic and precision equipment manufacturing. The FDA serves as the contracting agency, with designated points of contact available for acquisition and contracting queries, though the Contracting Officer has yet to be determined.